Bcr-Abl stabilizes β-catenin in chronic myeloid leukemia through its tyrosine phosphorylation
Open Access
- 22 February 2007
- journal article
- research article
- Published by Springer Science and Business Media LLC in The EMBO Journal
- Vol. 26 (5), 1456-1466
- https://doi.org/10.1038/sj.emboj.7601485
Abstract
Self‐renewal of Bcr‐Abl+ chronic myeloid leukemia (CML) cells is sustained by a nuclear activated serine/threonine‐(S/T) unphosphorylated β‐catenin. Although β‐catenin can be tyrosine (Y)‐phosphorylated, the occurrence and biological relevance of this covalent modification in Bcr‐Abl‐associated leukemogenesis is unknown. Here we show that Bcr‐Abl levels control the degree of β‐catenin protein stabilization by affecting its Y/S/T‐phospho content in CML cells. Bcr‐Abl physically interacts with β‐catenin, and its oncogenic tyrosine kinase activity is required to phosphorylate β‐catenin at Y86 and Y654 residues. This Y‐phospho β‐catenin binds to the TCF4 transcription factor, thus representing a transcriptionally active pool. Imatinib, a Bcr‐Abl antagonist, impairs the β‐catenin/TCF‐related transcription causing a rapid cytosolic retention of Y‐unphosphorylated β‐catenin, which presents an increased binding affinity for the Axin/GSK3β complex. Although Bcr‐Abl does not affect GSK3β autophosphorylation, it prevents, through its effect on β‐catenin Y phosphorylation, Axin/GSK3β binding to β‐catenin and its subsequent S/T phosphorylation. Silencing of β‐catenin by small interfering RNA inhibited proliferation and clonogenicity of Bcr‐Abl+ CML cells, in synergism with Imatinib. These findings indicate the Bcr‐Abl triggered Y phosphorylation of β‐catenin as a new mechanism responsible for its protein stabilization and nuclear signalling activation in CML.This publication has 40 references indexed in Scilit:
- Chronic Myeloid Leukemia:Cell, 2004
- Granulocyte–Macrophage Progenitors as Candidate Leukemic Stem Cells in Blast-Crisis CMLNew England Journal of Medicine, 2004
- Efficacy of dual-specific Bcr-Abl and Src-family kinase inhibitors in cells sensitive and resistant to imatinib mesylateLeukemia, 2004
- Role for ICAT in β-catenin-dependent nuclear signaling and cadherin functionsAmerican Journal of Physiology-Cell Physiology, 2004
- Convergence of Wnt, ß-Catenin, and Cadherin PathwaysScience, 2004
- Further evidence that the tyrosine phosphorylation of glycogen synthase kinase-3 (GSK3) in mammalian cells is an autophosphorylation eventBiochemical Journal, 2004
- Chronic Myeloid Leukemia — Advances in Biology and New Approaches to TreatmentNew England Journal of Medicine, 2003
- A role for Wnt signalling in self-renewal of haematopoietic stem cellsNature, 2003
- p120 Catenin-Associated Fer and Fyn Tyrosine Kinases Regulate β-Catenin Tyr-142 Phosphorylation and β-Catenin-α-Catenin InteractionMolecular and Cellular Biology, 2003
- Tumor formation by genetic mutations in the components of the Wnt signaling pathwayCancer Science, 2003